Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Pharmaceutical Excipients Market: By Product: Organic Chemicals, Inorganic Chemicals, Others; By Functionality: Fillers & Diluents, Suspending & Viscosity Agents, Others; By Formulation; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Pharmaceutical Excipients Market Outlook
The global pharmaceutical excipients market is projected to attain USD 9.8 billion by 2026, rising from USD 7.6 billion in 2020, growing at a CAGR of 4% between 2021 and 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
A pharmaceutical excipient, also referred to as a bulking agent, diluent, or filler, is an organic or synthetic product formulated with the active ingredient of a drug, included in a pharmaceutical dosage form to assist in the manufacturing process to protect, support, or enhance stability, or for bioavailability. They also help to identify products and improve general product safety or functionality during storage or use.
Properties and Applications
The pharmaceutical excipients market can be divided based on segments like product, functionality, and formulation.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The pharmaceutical excipients market can be divided based on its product as organic chemicals and inorganic chemicals. Organic chemicals can be further subdivided into oleochemicals, carbohydrates, petrochemicals, and proteins. Carbohydrates are also further subdivided into sugars, cellulose, and starch. Inorganic chemicals, meanwhile, are divided into calcium phosphate, metal oxides, halites, calcium carbonate, and calcium sulphate. The pharmaceutical excipients market can be broadly categorised based on its formulation into:
- Oral Formulations
- Tablets
- Capsules
- Hard Gelatin Capsules
- Soft Gelatin Capsules
- Liquid Formulations
- Topical Formulations
- Parenteral Formulations
- Others
The pharmaceutical excipients market can be divided on the basis of its functionality into fillers and diluents, suspending and viscosity agents, coating agents, binders, flavouring agents and sweeteners, disintegrants, colourants, lubricants and glidants, preservatives, and emulsifying agents, among others.
The EMR report looks into the regional pharmaceutical excipients market like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The pharmaceutical excipients market is driven by factors such as the growing pharmaceutical industry combined with advances in functional excipients, increased use of orphan drugs, and the increased use of biopharmaceuticals. The advent of multifunctional excipients, the shifting focus of pharmaceutical manufacturing to emerging markets, and the increasing biosimilar sector also pose important growth possibilities in the pharmaceutical excipients market for the market players.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global pharmaceutical excipients market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Dupont De Nemours, Inc.
- Roquette Frères
- Ashland Global Holdings Inc.
- Evonik Industries AG
- BASF SE
- Kerry Group PLC
- Croda International Plc
- ABF Ingredients Limited
- Archer Daniels Midland Company
- The Lubrizol Corporation
- Innophos Holdings Inc.
- WACKER Chemie AG
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Functionality, Formulation, Region |
| Breakup by Product | Organic Chemicals, Inorganic Chemicals, Others |
| Breakup by Functionality | Fillers & Diluents, Suspending & Viscosity Agents, Coating Agents, Binders, Flavouring Agents & Sweeteners, Disintegrants, Colourants, Lubricants & Glidants, Preservatives, Emulsifying Agents, Others |
| Breakup by Formulation | Oral Formulations, Topical Formulations, Parenteral Formulations, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Dupont De Nemours, Inc., Roquette Frères, Ashland Global Holdings Inc., Evonik Industries AG, BASF SE, Kerry Group PLC, Croda International Plc, ABF Ingredients Limited, Archer Daniels Midland Company, The Lubrizol Corporation, Innophos Holdings Inc., WACKER Chemie AG, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Pharmaceutical Excipients Market Analysis
8.1 Key Industry Highlights
8.2 Global Pharmaceutical Excipients Historical Market (2017-2021)
8.3 Global Pharmaceutical Excipients Market Forecast (2022-2027)
8.4 Global Pharmaceutical Excipients Market by Product
8.4.1 Organic Chemicals
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.1.4 Breakup by Type
8.4.1.4.1 Oleochemicals
8.4.1.4.2 Carbohydrates
8.4.1.4.2.1 Sugar
8.4.1.4.2.2 Cellulose
8.4.1.4.2.3 Starch
8.4.1.4.3 Petrochemicals
8.4.1.4.4 Proteins
8.4.1.4.5 Others
8.4.2 Inorganic Chemicals
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.2.4 Breakup by Type
8.4.2.4.1 Calcium Phosphate
8.4.2.4.2 Metal Oxides
8.4.2.4.3 Halites
8.4.2.4.4 Calcium Carbonate
8.4.2.4.5 Calcium Sulphate
8.4.2.4.6 Others
8.4.3 Others
8.5 Global Pharmaceutical Excipients Market by Functionality
8.5.1 Filers and Diluents
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Suspending and Viscosity Agents
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Coating Agents
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Binders
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2017-2021)
8.5.4.3 Forecast Trend (2022-2027)
8.5.5 Flavoring Agents and Sweeteners
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2017-2021)
8.5.5.3 Forecast Trend (2022-2027)
8.5.6 Disintegrants
8.5.6.1 Market Share
8.5.6.2 Historical Trend (2017-2021)
8.5.6.3 Forecast Trend (2022-2027)
8.5.7 Colourants
8.5.7.1 Market Share
8.5.7.2 Historical Trend (2017-2021)
8.5.7.3 Forecast Trend (2022-2027)
8.5.8 Lubricants and Glidants
8.5.8.1 Market Share
8.5.8.2 Historical Trend (2017-2021)
8.5.8.3 Forecast Trend (2022-2027)
8.5.9 Preservatives
8.5.9.1 Market Share
8.5.9.2 Historical Trend (2017-2021)
8.5.9.3 Forecast Trend (2022-2027)
8.5.10 Emulsifying Agents
8.5.10.1 Market Share
8.5.10.2 Historical Trend (2017-2021)
8.5.10.3 Forecast Trend (2022-2027)
8.5.11 Others
8.6 Global Pharmaceutical Excipients Market by Formulation
8.6.1 Oral Formulations
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.1.4 Breakup by Type
8.6.1.4.1 Tablets
8.6.1.4.2 Capsules
8.6.1.4.2.1 Hard Gelatin Capsules
8.6.1.4.2.2 Soft Gelatin Capsules
8.6.1.4.3 Liquid Formulations
8.6.2 Topical Formulations
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Parenteral Formulations
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2017-2021)
8.6.3.3 Forecast Trend (2022-2027)
8.6.4 Others
8.7 Global Pharmaceutical Excipients Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 DuPont De Nemours, Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Roquette Frères S.A
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 BASF SE
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Evonik Industries Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Ashland Global Holdings Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Kerry Group Plc
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Croda International Plc
12.2.7.1 Company Overview
12.2.7.2 Product Portfolio
12.2.7.3 Demographic Reach and Achievements
12.2.7.4 Certifications
12.2.8 ABF Ingredients Limited
12.2.8.1 Company Overview
12.2.8.2 Product Portfolio
12.2.8.3 Demographic Reach and Achievements
12.2.8.4 Certifications
12.2.9 Archer Daniels Midland Company
12.2.9.1 Company Overview
12.2.9.2 Product Portfolio
12.2.9.3 Demographic Reach and Achievements
12.2.9.4 Certifications
12.2.10 The Lubrizol Corporation
12.2.10.1 Company Overview
12.2.10.2 Product Portfolio
12.2.10.3 Demographic Reach and Achievements
12.2.10.4 Certifications
12.2.11 Innophos Holdings, Inc.
12.2.11.1 Company Overview
12.2.11.2 Product Portfolio
12.2.11.3 Demographic Reach and Achievements
12.2.11.4 Certifications
12.2.12 WACKER Chemie AG
12.2.12.1 Company Overview
12.2.12.2 Product Portfolio
12.2.12.3 Demographic Reach and Achievements
12.2.12.4 Certifications
12.2.13 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Pharmaceutical Excipients Market: Key Industry Highlights, 2016 and 2026
2. Global Pharmaceutical Excipients Historical Market: Breakup by Product (USD Million), 2017-2021
3. Global Pharmaceutical Excipients Market Forecast: Breakup by Product (USD Million), 2022-2027
4. Global Pharmaceutical Excipients Historical Market: Breakup by Functionality (USD Million), 2017-2021
5. Global Pharmaceutical Excipients Market Forecast: Breakup by Functionality (USD Million), 2022-2027
6. Global Pharmaceutical Excipients Historical Market: Breakup by Formulation (USD Million), 2017-2021
7. Global Pharmaceutical Excipients Market Forecast: Breakup by Formulation (USD Million), 2022-2027
8. Global Pharmaceutical Excipients Historical Market: Breakup by Region (USD Million), 2017-2021
9. Global Pharmaceutical Excipients Market Forecast: Breakup by Region (USD Million), 2022-2027
10. North America Pharmaceutical Excipients Historical Market: Breakup by Country (USD Million), 2017-2021
11. North America Pharmaceutical Excipients Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Europe Pharmaceutical Excipients Historical Market: Breakup by Country (USD Million), 2017-2021
13. Europe Pharmaceutical Excipients Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Asia Pacific Pharmaceutical Excipients Historical Market: Breakup by Country (USD Million), 2017-2021
15. Asia Pacific Pharmaceutical Excipients Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Latin America Pharmaceutical Excipients Historical Market: Breakup by Country (USD Million), 2017-2021
17. Latin America Pharmaceutical Excipients Market Forecast: Breakup by Country (USD Million), 2022-2027
18. Middle East and Africa Pharmaceutical Excipients Historical Market: Breakup by Country (USD Million), 2017-2021
19. Middle East and Africa Pharmaceutical Excipients Market Forecast: Breakup by Country (USD Million), 2022-2027
20. Global Pharmaceutical Excipients Market Structure
Key Questions Answered in the Report
In 2020, the global pharmaceutical excipients market attained a value of nearly USD 7.6 billion.
The market is projected to grow at a CAGR of 4% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 9.8 billion by 2026.
The major drivers of the industry, such as the growth of the pharmaceutical sector, rising demand for OTC drugs, advancement in biotechnology, and the development of the multifunctional excipients, are expected to aid the market growth.
The key market trends guiding the growth of the pharmaceutical excipients market include growing technological advancements, and the launch of new products owing to increased research and development activities.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Organic chemicals and inorganic chemicals, among others, are the leading pharmaceutical excipients products in the industry.
Oral formulations, topical formulations, and parenteral formulations, among others, are the major formulations of the product in the market.
The significant functionalities of the product in the industry include fillers and diluents, suspending and viscosity agents, coating agents, binders, flavouring agents and sweeteners, disintegrants, colourants, lubricants and glidants, preservatives, and emulsifying agents, among others.
The major players in the industry are Dupont De Nemours, Inc., Roquette Frères, Ashland Global Holdings Inc., Evonik Industries AG, BASF SE, Kerry Group PLC, Croda International Plc, ABF Ingredients Limited, Archer Daniels Midland Company, The Lubrizol Corporation, Innophos Holdings Inc., WACKER Chemie AG, Others.
Analyst Review
The global pharmaceutical excipients market attained a value of USD 7.6 billion in 2020, driven by the thriving pharmaceuticals sector and the growing demand for multifunctional excipients. Aided by the technological advancements, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 4%. The pharmaceutical excipients market is projected to reach USD 9.8 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on products, the pharmaceutical excipients industry can be bifurcated into organic chemicals and inorganic chemicals, among others. On the basis of formulation, the industry can be categorised into oral formulations, topical formulations, and parenteral formulations, among others. By functionality, the market is segregated into fillers and diluents, suspending and viscosity agents, coating agents, binders, flavouring agents and sweeteners, disintegrants, colourants, lubricants and glidants, preservatives, and emulsifying agents, among others. The major regional markets for pharmaceutical excipients are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Dupont De Nemours, Inc., Roquette Frères, Ashland Global Holdings Inc., Evonik Industries AG, BASF SE, Kerry Group PLC, Croda International Plc, ABF Ingredients Limited, Archer Daniels Midland Company, The Lubrizol Corporation, Innophos Holdings Inc., WACKER Chemie AG, Others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global vaccine market attained a value of nearly USD 57.55 billion in 2021, driven by the rising prevalence of chronic illnesses worldwide. Aided by the growing investments in the pharmaceutical i...
The global immunotherapy drugs market attained a value of nearly USD 179.6 billion in 2021, driven by the rising prevalence of cancer and other chronic illnesses worldwide. Aided by the growing invest...
The global anisole market attained a value of about USD 94.09 million in 2021, driven by the rising application of anisole in the pharmaceutical industry. Aided by the thriving e-commerce industry, th...
The global antiviral drugs market attained a value of more than USD 62.7 billion in 2021, driven by the rising cases of viral infections among the geriatrics, and rising healthcare expenditure. The ma...
The global oral antibiotics market attained a value of over USD 18,365.8 million in 2021, driven by the extensive use of oral antibiotics for the treatment of infectious diseases. Aided by the growing...
NEWSLETTER